View All News

Lygos Closes Series B Financing

We are excited to announce the close of Lygos’ $15.5MM Series B round of financing. Led by IA Ventures and First Round Capital, these funds will be used to accelerate commercialization of our pipelined products and expand our technology platform. Having successfully developed a bio-based route to malonates, we now look forward to bringing new aspartic, glycolic, and lactic acid technologies to market, among others.

Read more:

Lygos Raises $15.5 Million to Accelerate Delivery of Clean and Sustainable Biology-Based Performance Materials. Globe Newswire (July 2018)

More News
March 11, 2019
Lygos Awarded Three Innovation Research Grants to Advance Applications for its Portfolio of Sustainable Specialty Biochemicals
February 20, 2019
Lygos Partners with Leading Materials Scientists at the University of Massachusetts to Expand Applications of its Bio-Malonicâ„¢ Acid Product Family
January 23, 2019
LG Technology Ventures Makes Strategic Investment in Lygos